4.4 Article

Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV

Related references

Note: Only part of the references are listed.
Review Cell Biology

Memory and CAR-NK cell-based novel approaches for HIV vaccination and eradication

Abdulbaset Mazarzaei et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Biochemistry & Molecular Biology

Broadly Neutralizing Antibodies against HIV: Back to Blood

Amir Dashti et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform

Eytan Herzig et al.

Article Immunology

CD4+ T Cell Subsets and Pathways to HIV Latency

Luis M. Agosto et al.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)

Review Biochemistry & Molecular Biology

Cellular and molecular mechanisms of HIV-1 integration targeting

Alan N. Engelman et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Biochemistry & Molecular Biology

Rewiring T-cell responses to soluble factors with chimeric antigen receptors

Zenan L. Chang et al.

NATURE CHEMICAL BIOLOGY (2018)

Article Infectious Diseases

Quarter Century of Anti-HIV CAR T Cells

Thor A. Wagner

CURRENT HIV/AIDS REPORTS (2018)

Article Medicine, Research & Experimental

Stable Transcriptional Repression and Parasitism of HIV-1

Surya Shrivastava et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Article Oncology

CART cells are prone to Fas- and WDR5-mediated cell death

Benjamin O. Tschumi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Article Medicine, Research & Experimental

Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity

Dongrui Wang et al.

JCI INSIGHT (2018)

Article Biotechnology & Applied Microbiology

Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells

Malika Hale et al.

MOLECULAR THERAPY (2017)

Review Immunology

How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design

Marie Pancera et al.

CURRENT OPINION IN HIV AND AIDS (2017)

Article Immunology

Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies

Ruijiang Song et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)

Article Biotechnology & Applied Microbiology

Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells

Adam P. Cribbs et al.

BMC BIOTECHNOLOGY (2013)

Article Multidisciplinary Sciences

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

Florian Klein et al.

NATURE (2012)

Article Biotechnology & Applied Microbiology

Systematic determination of the packaging limit of lentiviral vectors

M Kumar et al.

HUMAN GENE THERAPY (2001)